RankAlpha logo
Back to Rankings

PCVX

VaxcyteC
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
10
U.S. public peers
Grade Position
In line
vs peer average
PCVX vs peer average
63/100
PCVX vs. peer average (C vs. D)
Grade spread
B 1 · C 2 · D 5 · F 2
Graded peers loaded
Coverage
10 graded
100% of tracked

Peer overview

MRK is the first available peer comparator.

Direct operating comparator through Capvaxive, the approved PCV21 benchmark used in OPUS-1's head-to-head design. Merck is more useful as a commercial and competitive benchmark than as a like-for-like valuation peer because PCVX remains pre-commercial. [#PR-EARNINGS-2026-08-05] [#MRK-CAPVAXIVE]

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerMRKMerck
PCVX
Vaxcyte
MRK
Merck
Grade
C
C
Momentum
56
82
Value
41
62
Sentiment
65
54
Setup Bias
Net —
-
Market Cap
-
-
Posture
Mixed
Mixed

Grade position vs MRK

PCVX / MRK
Grade Position
In line
PCVX vs. peer average (C vs. D)
63/100
Momentum
56
MRK
Value
41
MRK
Sentiment
65
PCVX

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PCVX
1
MRK
MRK
C
60/100
Even
2
PFE
PFE
B
80/100
-1
3
IMVT
Immunovant Inc Common
D
40/100
+1
4
AVTR
Avantor Inc Common
F
20/100
+2
5
BRKR
Bruker Corp Common
D
40/100
+1
MRK is the first peer returned for this comparison set.